Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 05:04:35 - browse：1

Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： Organ aging and disease risk measured by new blood test

entertainment

WSS

Families look for replacement for GSK asthma drug Flovent

CDC director unscathed in first congressional testimony

The untold story of TV’s first prescription drug ad

The untold story of TV’s first prescription drug ad

Pediatric cancer treatments threatened by a new FDA policy

How to pay for weight loss drugs and save Medicare

hotspot

Wikipedia

focus

Guidelines to prevent youth baseball injuries need more muscle

State of the Union pitch: Bigger Medicare drug price negotiations

Medical leaders decry Supreme Court decision on affirmative action

What to do when lifesaving products contribute to climate change

Alkermes shareholders re

Will the market for weight loss drugs really reach $100 billion?

Virginia high school admissions case could be legal follow

Florida health officials providing scant details on measles cases

Psychedelics group wrestles with new pharma identity

Harvard's David Sinclair gets blowback over aging

leisure time

For AI in health care standards, federal regulators join with industry group

$1 billion proposal to grow Boston, Massachusetts biotech

Medicare drug price negotiation hearing pits pharma v Biden admin

Biden's 'march

FDA investigates CAR

The public health thinking behind the CDC’s new Covid guidance

hotspot

entertainment

entertainment

knowledge